Global Resource Corporation (GBRC.OB) Announces Results from Energy Conversion Engine
Medical news always grabs attention in the stock community, especially when it involves cancer. That's why it's no surprise that share prices for Northwest Biotherapeautics Inc. (OTCBB: NWBO) skyrocketed a whopping 135 percent by midday after the company announced that it had developed the world's first commercially available brain cancer vaccine.According to a recent Northwest statement, the company's DCVax-Brain platform technology has been approved for commercial use in Switzerland, making it the first commercially available therapeutic vaccine for brain cancer victims. The statement claims that both newly diagnosed and recurrent brain cancer patients treated with DCVax-Brain had "more than double"…